EHAB Logo

Enhabit, Inc. (EHAB) 

NYSE
Market Cap
$428.67M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
185 of 963
Rank in Industry
6 of 45

Largest Insider Buys in Sector

EHAB Stock Price History Chart

EHAB Stock Performance

About Enhabit, Inc.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.

Insider Activity of Enhabit, Inc.

Over the last 12 months, insiders at Enhabit, Inc. have bought $491,727 and sold $5,586 worth of Enhabit, Inc. stock.

On average, over the past 5 years, insiders at Enhabit, Inc. have bought $660,887 and sold $5,586 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Bolton Jeffrey (director) — $341,577. MCGUIGAN STUART M (director) — $264,300. Hoeflinger Erin (director) — $18,000.

The last purchase of 15,000 shares for transaction amount of $132,150 was made by MCGUIGAN STUART M (director) on 2024‑12‑10.

List of Insider Buy and Sell Transactions, Enhabit, Inc.

2024-12-10Purchasedirector
15,000
0.0306%
$8.81$132,150-0.70%
2024-11-12Purchasedirector
3,000
0.006%
$7.60$22,800+1.58%
2024-11-08Purchasedirector
7,000
0.0139%
$7.77$54,377-2.03%
2024-08-22Purchasedirector
5,000
0.0099%
$8.01$40,050-3.62%
2024-08-09Purchasedirector
5,000
0.0098%
$8.29$41,450-7.09%
2024-08-08Purchasedirector
2,000
0.004%
$8.60$17,200-7.57%
2024-05-17Purchasedirector
10,000
0.0193%
$8.33$83,300-1.15%
2024-05-14Purchasedirector
2,000
0.004%
$9.00$18,000-9.72%
2024-05-10Purchasedirector
10,000
0.0197%
$8.24$82,400-1.44%
2024-03-01SaleEVP Clinical Excel. & Strategy
634
0.0013%
$8.81$5,586-1.99%
2023-05-26Purchasedirector
2,000
0.004%
$11.61$23,220-7.53%
2023-05-22Purchasedirector
10,000
0.0198%
$11.98$119,800-12.08%
2023-05-18PurchaseEVP Clinical Excel. & Strategy
10,000
0.02%
$11.99$119,900-10.68%
2023-05-18Purchasedirector
2,100
0.0042%
$11.82$24,822-10.68%
2023-05-17Purchasedirector
2,000
0.0039%
$11.80$23,600-10.81%
2022-11-18Purchasedirector
1,000
0.002%
$12.69$12,690-0.93%
2022-11-09Purchasedirector
2,000
0.004%
$12.75$25,500+0.08%
2022-11-08Purchasedirector
2,000
0.004%
$12.89$25,780-1.77%
2022-11-08Purchasedirector
426
0.0009%
$13.57$5,781-1.77%
2022-11-07Purchasedirector
8,300
0.0163%
$12.69$105,327-2.15%

Insider Historical Profitability

<0.0001%
Bolton Jeffreydirector
94144
0.1872%
$8.53130<0.0001%
Langham Ronald Leroy JREVP Clinical Excel. & Strategy
57164
0.1137%
$8.5311<0.0001%
MCGUIGAN STUART Mdirector
46810
0.0931%
$8.5310
Hoeflinger Erindirector
30399
0.0605%
$8.5330<0.0001%
Jacobsmeyer Barbara AnnPresident and CEO
238442
0.4742%
$8.5310+3.36%
SHAW L EDWARD JRdirector
38989
0.0775%
$8.5320<0.0001%
LaMonica Susan
23095
0.0459%
$8.5310+8.59%
ELSON CHARLES M
22069
0.0439%
$8.5310<0.0001%
CURL YVONNE M
17608
0.035%
$8.5310+0.22%
MAUPIN JOHN E JR D D S
17390
0.0346%
$8.5310+0.22%
Rush Gregory Sdirector
16597
0.033%
$8.5320<0.0001%
Brown-Stevenson Tina L.
9645
0.0192%
$8.5310<0.0001%
HIGDON LEO I JRdirector
7926
0.0158%
$8.5330+2.31%
Marion Tanya ReneeChief Human Resources Officer
1712
0.0034%
$8.5310<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$93.2M15.958M-1.17%-$1.1M<0.01
Deerfield Management$58.22M9.965M0%+$00.14
The Vanguard Group$53.95M9.234.63M-18.85%-$12.53M<0.01
AREX Capital Management, LP$28.12M4.812.41M-0.03%-$9,424.8531.49
State Street$23.2M3.971.99M-0.82%-$190,920.20<0.01
Kempen Capital Management N V$22.9M3.921.97M-10.96%-$2.82M0.29
Dimensional Fund Advisors$20.15M3.451.73M-7.27%-$1.58M0.01
Systematic Financial Management LLC$19.53M3.341.68M+6.1%+$1.12M0.55
UBS$19.02M3.261.63M-2%-$388,993.500.01
Margate Capital Management LP$18.62M3.191.6M-17.45%-$3.94M2.86
Paradice Investment Management$17.64M3.021.51M-24.43%-$5.7M3.06
Schroder Investment Management Group$16.67M2.851.43M+5.03%+$798,432.770.02
Geode Capital Management$12.69M2.171.09M+2.15%+$266,772.24<0.01
Charles Schwab$12.24M2.091.05M+8.67%+$976,689.39<0.01
Morgan Stanley$10.82M1.85928,886+12.8%+$1.23M<0.01
Invesco$8.59M1.47736,916+19.64%+$1.41M<0.01
Point72 Asset Management$8.12M1.39696,800New+$8.12M0.01
Orchard Capital Managment Llc$7.08M1.21607,891+1.26%+$87,852.652.08
Ameriprise Financial$6.84M1.17587,406+4.47%+$292,706.13<0.01
Northern Trust$5.85M1502,197-2.14%-$128,196.60<0.01
Empyrean Capital Partners$5.71M0.98490,0000%+$00.44
Kent Lake Capital LLC$5.18M0.89444,874New+$5.18M2.34
D. E. Shaw & Co.$4.76M0.82408,662+37.09%+$1.29M0.01
BNY Mellon$4.6M0.79394,639-4.5%-$216,387.13<0.01
DekaBank$3.86M0.68340,412+38.99%+$1.08M0.01
Prescott Group Capital Management LLC$3.88M0.67333,450+29.53%+$885,726.410.46
Bridgeway Capital Management$3.87M0.66331,894+60.78%+$1.46M0.06
Woodline Partners LP$3.85M0.66330,605New+$3.85M0.03
Prelude Capital$3.64M0.62312,385-21.86%-$1.02M0.27
Goldman Sachs$3.54M0.61304,045-10.12%-$398,709.68<0.01
Citadel Advisors LLC$3.1M0.53266,237New+$3.1M<0.01
Nuveen$2.9M0.5248,892-28.64%-$1.16M<0.01
Deutsche Bank$2.54M0.44218,040+0.23%+$5,941.50<0.01
Boothbay Fund Management LLC$2.41M0.41206,898+2.24%+$52,774.510.08
Barclays$2.21M0.38189,283+19.89%+$365,878.82<0.01
Cruiser Capital Advisors, LLC$2.15M0.37184,142-81.83%-$9.66M3.23
Tudor Investment Corp Et Al$2.05M0.35175,782+40.47%+$590,002.510.02
RhumbLine Advisers$1.91M0.33163,775+1.22%+$22,903.63<0.01
Bardin Hill Investment Partners LP$1.73M0.3148,398-63.22%-$2.97M1
Empowered Funds Llc$1.72M0.29147,594+87.71%+$803,453.850.03
Jane Street Capital$1.71M0.29146,448+218.55%+$1.17M<0.01
Hrt Financial Llc$1.68M0.29144,191New+$1.68M0.01
Trexquant Investment LP$1.66M0.29142,727New+$1.66M0.03
Bank of America$1.67M0.29143,085+30.75%+$392,034.09<0.0001
Legal & General$1.6M0.27137,062-0.22%-$3,588.12<0.0001
West Tower Group Llc$1.59M0.27136,576-28.07%-$621,049.694.8
Centerbook Partners Lp$1.45M0.25124,692-0.82%-$12,022.800.1
Sasco Capital Inc Ct$1.38M0.24118,045+9.85%+$123,256.980.18
Kennedy Capital Management Inc$1.32M0.23113,004-1.35%-$18,045.850.03
Public Sector Pension Investment Board$1.21M0.21104,0340%+$00.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.